Implications of Stem Cells in Multiple Sclerosis Research and Treatment

Director of the Experimental Therapeutics Program in Cleveland Clinic’s Mellen Center for Multiple Sclerosis, Jeffrey Cohen, MD, shares insights on how stem cell-based therapies may provide revolutionary treatment options for neurological disorders and deliver exciting prospects in modern medicine. For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.